BNP Paribas Financial Markets’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5K Buy
5,368
+2,891
+117% +$9.81K ﹤0.01% 5301
2026
Q1
$10.4K Hold
2,477
﹤0.01% 5213
2025
Q4
$10.7K Buy
2,477
+1,238
+100% +$4.72K ﹤0.01% 5146
2025
Q3
$5.38K Buy
1,239
+839
+210% +$3.78K ﹤0.01% 5087
2025
Q2
$1.86K Buy
+400
New +$1.58K ﹤0.01% 5069

Other funds holding SBC

BNP Paribas Financial Markets's SBC Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its SBC Medical Group (SBC) stake by 117% in Q2 2026, buying an estimated $9.81K and bringing the position to 5,368 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5301.

BNP Paribas Financial Markets first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 50 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • BNP Paribas Financial Markets held 5,368 shares of SBC Medical Group worth $16.5K as of Q2 2026.
  • BNP Paribas Financial Markets bought 2,891 SBC Medical Group shares in Q2 2026, an estimated $9.81K.
  • SBC Medical Group made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5301 holding.
  • BNP Paribas Financial Markets first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.